VIBONATE 120ARTESUNATE 120mg. IP + SODIUM BICARBONATE 5% IP + SODIUM CHLORIDE 0.9w/v IP

Vibonate 120 injection contains artesunate 120 mg and is used for the treatment of severe malaria. Main uses: treatment of severe malaria caused by Plasmodium falciparum; used in hospitals when the patient cannot take malaria medicines by mouth; used as the starting treatment for severe malaria before follow-up medicines are given; used for severe malaria in adults and children, including in pregnancy, under medical supervision.

Common side effects of Vibonate 120 Injection include haemolysis (breakdown of red blood cells) and anaemia, sometimes delayed after treatment; low white cell count (neutropenia or leukopenia); raised liver enzymes (AST or ALT); low blood sugar (hypoglycaemia); dizziness; nausea or vomiting. Get medical help at once if you notice severe delayed haemolysis with anaemia; severe allergic reaction including anaphylaxis; significant liver injury.

Vibonate 120 Injection contains Artesunate 120 mg + Sodium Bicarbonate 5% + Sodium Chloride 0.9w/v. Vibonate 120 Injection is given by a doctor or nurse, who decides the dose and how often it is given.

The MRP of Vibonate 120 Injection is ₹355 for a pack of 1’s. For chemists and distributors, the PTR is ₹270.48 and the PTS is ₹243.43.

Vibonate 120 Injection contains Artesunate 120 mg + Sodium Bicarbonate 5% + Sodium Chloride 0.9w/v. It comes in a pack of 1’s.

Artesunate acts on the malaria parasite while it is inside the red blood cells, so the infection is brought under control. Sodium bicarbonate solution helps to dissolve the artesunate powder before use, and sodium chloride 0.9 w/v is used to dilute the dissolved medicine so that it can be given as an injection.

Must not be used in anyone who is allergic to artesunate, any artemisinin medicine or any ingredient of this injection. Must not be used in patients who are losing chloride by vomiting or from continuous gastrointestinal suction, as the injection contains sodium bicarbonate. Must not be used in patients receiving diuretics known to produce a hypochloremic alkalosis. Check with a doctor first: sodium-containing solutions must be used with great care, if at all, in patients with congestive heart failure, severe renal insufficiency or oedema with sodium retention, since sodium may be retained and intravenous fluid can overload the circulation and cause pulmonary oedema; liver disease also needs medical review first. Check with a doctor first if the patient is pregnant or breastfeeding.

Vibonate 120 Injection is a brand of Vibcare Pharma, sold through its Genvimax division. It is available for PCD pharma franchise and distribution in India; use the Send Enquiry or WhatsApp button on this page to ask about availability and terms.